世界の二重特異性抗体市場は、2022年に約57億3,000万米ドルと評価され、予測期間の2023年から2030年にかけて44.0％以上の健全な成長率で成長すると予測されています。二特異性抗体は、2つの異なる標的分子に同時に結合するように作られた治療用タンパク質の一種です。これらの抗体は、遺伝子工学的手法により、異なる抗原またはレセプターを認識する2つの別々の抗原結合部位を有しています。二特異性抗体は、2つの異なる標的分子に結合することによって、これらの分子を組み立てたり、相互作用を制御したり、あるいは体の部位に薬効物質を運搬したりします。二特異性抗体は、通常単一の標的に結合する従来のモノクローナル抗体と比較して、いくつかの利点があります。二重特異性抗体は、多数の疾患関連経路を同時に標的としたり、免疫細胞を健康な組織から腫瘍細胞へと誘導したりするために使用されます。標的療法や個別化療法への需要の高まり、抗体工学技術の著しい進歩、国内外の利害関係者間の共同研究やパートナーシップの増加が、推定期間中の市場需要を促進している主な要因となっています。
加えて、がん患者の急増は、免疫チェックポイント阻害薬やT細胞エンゲイジャーとして設計されたものを中心とする生物特異的抗体を含む様々な代替治療への需要を後押しし、世界全体の市場成長を加速させています。The Global Cancer Observatory（GCO）によると、2020年には世界中で約1,930万人のがん患者が新たに報告され、この数は2040年には3,020万人に増加すると予想されています。生物特異的抗体は、腫瘍細胞を攻撃するよう免疫細胞を誘導し、腫瘍の退縮と患者の転帰の改善をもたらします。さらに、生物製剤の研究開発への投資の増加や、バイオ医薬品のパイプラインの堅調な成長は、予測期間中に様々な有利な機会をもたらします。しかし、複雑な市場開拓と製造、規制上の課題が、2023年から2030年の予測期間を通じて市場成長に課題しています。
世界の二重特異性抗体市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカが含まれます。北アメリカは、規制当局による二重特異性抗体の承認の増加、研究開発活動への投資の増加、いくつかの主要な市場プレイヤーの存在により、2022年の市場を独占しました。例えば、2022年10月に初の二重特異性B細胞成熟抗原であるteclistamab-cqyv（Tecvayli、Janssen Biotech, Inc.）がFDAの承認を取得しました。さらに、二重特異性抗体を創製するために、補完的な科学的専門知識や技術を利用するためのパートナーシップや共同研究に参加する企業も増えています。こうしたパートナーシップは研究開発のイニシアチブを促進し、市場拡大をさらに加速させています。ヨーロッパは予測期間中に大幅なCAGRで成長すると予想されています。二重特異性抗体の需要の急増、技術的進歩への注目の高まり、国内外の利害関係者間の共同研究やパートナーシップの増加が、同地域全体の市場需要を大きく促進しています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Bispecific Antibodies Market, by Region, 2020-2030 (USD Billion)
1.2.2. Bispecific Antibodies Market, by Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bispecific Antibodies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bispecific Antibodies Market Dynamics
3.1. Bispecific Antibodies Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing demand for targeted and personalized therapies
3.1.1.2. Surge in the incidences of cancer cases
3.1.2. Market Challenges
3.1.2.1. Complex development and manufacturing
3.1.2.2. Regulatory challenges
3.1.3. Market Opportunities
3.1.3.1. Increasing investment in biologics research and development
3.1.3.2. Robust growth of the biopharmaceutical pipeline
Chapter 4. Global Bispecific Antibodies Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Bispecific Antibodies Market, by Indication
5.1. Market Snapshot
5.2. Global Bispecific Antibodies Market by Indication, Performance - Potential Analysis
5.3. Global Bispecific Antibodies Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
5.4. Bispecific Antibodies Market, Sub Segment Analysis
5.4.1. Cancer
5.4.2. Inflammatory & Autoimmune Disorders
5.4.3. Others
Chapter 6. Global Bispecific Antibodies Market, Regional Analysis
6.1. Top Leading Countries
6.2. Top Emerging Countries
6.3. Bispecific Antibodies Market, Regional Market Snapshot
6.4. North America Bispecific Antibodies Market
6.4.1. U.S. Bispecific Antibodies Market
6.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
6.4.2. Canada Bispecific Antibodies Market
6.5. Europe Bispecific Antibodies Market Snapshot
6.5.1. U.K. Bispecific Antibodies Market
6.5.2. Germany Bispecific Antibodies Market
6.5.3. France Bispecific Antibodies Market
6.5.4. Spain Bispecific Antibodies Market
6.5.5. Italy Bispecific Antibodies Market
6.5.6. Rest of Europe Bispecific Antibodies Market
6.6. Asia-Pacific Bispecific Antibodies Market Snapshot
6.6.1. China Bispecific Antibodies Market
6.6.2. India Bispecific Antibodies Market
6.6.3. Japan Bispecific Antibodies Market
6.6.4. Australia Bispecific Antibodies Market
6.6.5. South Korea Bispecific Antibodies Market
6.6.6. Rest of Asia Pacific Bispecific Antibodies Market
6.7. Latin America Bispecific Antibodies Market Snapshot
6.7.1. Brazil Bispecific Antibodies Market
6.7.2. Mexico Bispecific Antibodies Market
6.8. Middle East & Africa Bispecific Antibodies Market
6.8.1. Saudi Arabia Bispecific Antibodies Market
6.8.2. South Africa Bispecific Antibodies Market
6.8.3. Rest of Middle East & Africa Bispecific Antibodies Market
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Amgen, Inc.
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Recent Developments
7.3.2. Bayer AG
7.3.3. Dow Pharmaceutical Solutions
7.3.4. ImmunGene, Inc.
7.3.5. Immunocore Limited
7.3.6. Merck & Co., Inc.
7.3.7. Novartis AG
7.3.8. Pfizer, Inc.
7.3.9. F. Hoffmann-La Roche AG
7.3.10. Akeso, Inc.
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Bispecific Antibodies Market, report scope
TABLE 2. Global Bispecific Antibodies Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Bispecific Antibodies Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 4. Global Bispecific Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 5. Global Bispecific Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Bispecific Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Bispecific Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Bispecific Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Bispecific Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Bispecific Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Bispecific Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Bispecific Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Bispecific Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. U.S. Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 16. U.S. Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. Canada Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. Canada Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. UK Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. UK Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Germany Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. Germany Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. France Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. France Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Italy Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. Italy Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Spain Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Spain Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. RoE Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. RoE Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. China Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. China Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. India Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. India Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. Japan Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. Japan Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. South Korea Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. South Korea Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Australia Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. Australia Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. RoAPAC Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. RoAPAC Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Brazil Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. Brazil Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Mexico Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Mexico Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. RoLA Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. RoLA Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Saudi Arabia Bispecific Antibodies Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. South Africa Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoMEA Bispecific Antibodies Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Bispecific Antibodies Market
TABLE 69. List of primary sources, used in the study of global Bispecific Antibodies Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Bispecific Antibodies Market, research methodology
FIG 2. Global Bispecific Antibodies Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Bispecific Antibodies Market, key trends 2022
FIG 5. Global Bispecific Antibodies Market, growth prospects 2023-2030
FIG 6. Global Bispecific Antibodies Market, porters 5 force model
FIG 7. Global Bispecific Antibodies Market, pest analysis
FIG 8. Global Bispecific Antibodies Market, value chain analysis
FIG 9. Global Bispecific Antibodies Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Bispecific Antibodies Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Bispecific Antibodies Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Bispecific Antibodies Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Bispecific Antibodies Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Bispecific Antibodies Market, regional snapshot 2020 & 2030
FIG 15. North America Bispecific Antibodies Market 2020 & 2030 (USD Billion)
FIG 16. Europe Bispecific Antibodies Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Bispecific Antibodies Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Bispecific Antibodies Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Bispecific Antibodies Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
